Single-Cell RNA Sequencing in Ovarian Cancer: Current Progress and Future Prospects
Progress in Biophysics and Molecular Biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Language: Английский
Utility of SOX17 Immunohistochemical Stain in Serous Fluid Cytology Cell Block Specimens
Diagnostic Cytopathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 17, 2025
ABSTRACT
Background
The
identification
of
metastatic
tumors
in
serous
fluid
cytology
specimens
(SFCS)
has
always
been
a
challenge.
In
this
study,
we
explored
SOX17
as
an
immunohistochemical
(IHC)
marker
for
the
diagnosis
gynecologic
body
specimens.
Methods
We
selected
97
tumor
cases,
including
85
SFCS
with
adequate
cell
block
material
(from
primary,
n
=
30
and
others,
55)
12
histology
(thymic
thyroid
tumors).
IHC
was
performed
on
all
results
were
interpreted
positive
or
negative.
Positive
further
characterized
by
intensity
(nuclear
staining)
weak
(1+),
moderate
(2+),
strong
(3+)
percentage
cells
focal
(<
10%),
patchy
(10%–50%)
diffuse
(>
50%).
Results
primary
tumors,
exhibited
nuclear
staining
28
out
two
cases
showing
staining.
All
non‐gynecologic
effusion
SOX17‐negative
except
one
case
renal
carcinoma,
which
displayed
pattern.
consisting
thymic
negative
SOX17.
Conclusions
tract
origin
positive,
while
other
case.
This
finding
suggests
that
is
excellent
addition
to
panel
working
up
at
sites,
specifically
when
are
differential
diagnosis.
Language: Английский
Clinicopathological Study of 34 Cases of Clear Cell Adenocarcinoma of the Urinary Tract and Diagnostic Value of SOX 17 in its Differential Diagnosis
Lan Zheng,
No information about this author
Georges Tabet,
No information about this author
Charles C. Guo
No information about this author
et al.
Human Pathology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 105767 - 105767
Published: April 1, 2025
Language: Английский
SOX17 expression in mesonephric‐like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Müllerian biomarker
Histopathology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 8, 2024
Aims
Recently,
SOX17
has
emerged
as
a
promising
biomarker
for
non‐mucinous
Müllerian
(ovarian
and
endometrial)
carcinomas,
demonstrating
increased
specificity
in
comparison
to
PAX8
while
maintaining
similar
sensitivity.
However,
expression
of
mesonephric‐like
adenocarcinoma
(MLA),
carcinoma
the
female
genital
tract
with
uncertain,
but
probably
histogenesis,
remains
unexplored.
This
study
aims
address
this
gap.
Methods
results
immunohistochemistry
was
performed
on
whole
tissue
sections
from
68
MLAs
originating
endometrium
or
ovary
seven
cervical
mesonephric
well
six
remnants/hyperplasias.
Using
four‐tiered
scoring
system
based
distribution
intensity
staining,
68%
MLA
displayed
negative/low
(<
10%)
pattern,
which
contrasts
high
observed
most
carcinomas.
22%
demonstrated
expression,
other
endometrial
ovarian
Similarly,
five
(72%)
carcinomas
cervix
were
SOX17‐negative,
two
cases
(28%)
positive.
All
remnants/hyperplasias
negative.
Conclusions
The
majority
are
negative
exhibit
low
contrast
diffuse
strong
commonly
seen
types
carcinoma.
subset
demonstrate
expression.
Therefore,
absence
staining
is
supportive
when
differential
includes
another
may
also
be
useful
differentiating
malignancies
benign
glandular
lesions.
Language: Английский
ZBTB7A regulates LncRNA HOTAIR-mediated ELAVL1/SOX17 axis to inhibit malignancy and angiogenesis in endometrial carcinoma
Journal of Cancer Research and Clinical Oncology,
Journal Year:
2024,
Volume and Issue:
150(7)
Published: July 9, 2024
Abstract
Background
Endometrial
cancer
(EC)
is
the
sixth
most
frequent
in
women
worldwide
and
has
higher
fatality
rates.
The
pathophysiology
of
EC
complex,
there
are
currently
no
reliable
methods
for
diagnosing
treating
condition.
Long
non-coding
RNA
(lncRNA),
according
to
mounting
evidence,
vital
EC.
HOTAIR
regarded
as
a
significant
prognostic
indicator
ZBTB7A
decreased
proliferation
migration,
recent
studies,
however
underlying
mechanism
still
needs
be
clarified.
Methods
research
utilized
RT-qPCR
measure
expression
clinical
tissues
various
cell
lines.
Kaplan-Meier
survival
analysis
was
employed
correlate
levels
with
patient
prognosis.
Additionally,
study
examined
interaction
between
using
bioinformatics
tools
ChIP
assays.
experimental
approach
also
involved
manipulating
lines
assessing
impact
on
cellular
processes
gene
expression.
Results
found
significantly
compared
adjacent
normal
tissues,
high
correlating
poorer
rates
advanced
characteristics.
like
HEC-1
A
KLE
showed
cells.
Knockdown
these
reduced
proliferation,
angiogenesis,
migration.
inversely
correlated
HOTAIR,
its
overexpression
led
decrease
reduction
malignant
behaviors.
uncovered
that
interacts
ELAVL1
regulate
SOX17,
which
turn
activates
Wnt/β-catenin
pathway,
promoting
behaviors
Conclusion
critical
regulator
EC,
contributing
tumor
growth
poor
Its
regulation
SOX17
via
pathway
underlines
potential
therapeutic
target.
Language: Английский
Identifying mesonephric‐like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry
Maryam Tahir,
No information about this author
Deyin Xing,
No information about this author
Qingqing Ding
No information about this author
et al.
Histopathology,
Journal Year:
2024,
Volume and Issue:
86(2), P. 268 - 277
Published: Sept. 4, 2024
Aims
Mesonephric‐like
adenocarcinoma
(MLA)
of
the
endometrium
or
ovary
is
a
rare
but
distinct
endometrial
carcinoma
which
has
combination
characteristic
morphological,
immunohistochemical
(IHC)
and
molecular
features.
SOX17
been
recently
identified
as
highly
sensitive
specific
marker
for
ovarian
carcinomas.
In
this
study,
we
aimed
to
investigate
expression
in
MLA
together
with
other
IHCs
differentiate
MLAs
from
Methods
Seventeen
previously
diagnosed
endometrial/ovarian
were
collected,
multiple
performed.
Additionally,
performed
SOX17,
PAX8
ER
on
tissue
microarrays
(TMAs)
composed
652
carcinomas
2012
2015
when
diagnostic
criteria
not
established.
Results
All
17
showed
diffuse
strong
positive
PAX8,
negative
variable
TTF1/GATA3
staining.
Notably,
all
(
n
=
10)
focal
weak/moderate
7)
staining
more
stronger
than
subtypes.
This
finding
prompted
us
screen
TMAs
before
by
an
approach
combined
IHCs,
14
cases
negative/focal
weak
identified.
We
further
studied
examining
morphology
performing
additional
(TTF1,
GATA3,
CD10)
would
classify
seven
(50%)
them
based
morphological
features
CD10,
TTF1
and/or
GATA3
Conclusion
Our
results
suggest
that
aid
diagnosing
if
show
SOX17.
Language: Английский
Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Müllerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens
Deepak Donthi,
No information about this author
Qiong Gan,
No information about this author
Qing Qing Ding
No information about this author
et al.
Cancer Cytopathology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 12, 2024
Abstract
Background
Trichorhinophalangeal
syndrome
1
(TRPS1)
expression
in
primary
breast
and
other
solid
tumors
has
been
investigated
but
its
role
as
a
marker
metastatic
is
unclear.
The
objective
of
this
study
was
to
evaluate
the
sensitivity
specificity
TRPS1
cancer
immunomarker
that
originated
from
breast,
Müllerian,
lung,
gastrointestinal
(GI),
pancreatic
with
cell
blocks
fine‐needle
aspiration
(FNA)
effusion
specimens.
Methods
Cell
were
immunostained
anti‐TRPS1
monoclonal
antibody
(clone
EPR16171).
Histochemical
scores
(H
scores)
(proportion
×
intensity;
range,
0–300)
assigned;
H
≥10
considered
positive.
Overall,
160
specimens
examined,
including
127
FNAs
(35
25
36
31
GI
carcinomas)
33
(18
12
one
two
carcinomas).
Results
positive
51
53
(96%)
carcinomas
28
107
(26.2%)
nonbreast
tumors.
Metastatic
carcinoma
showed
highest
mean
score
247.35,
compared
45.36
8.4
5.88
for
identifying
origin
96.22%
72.89%,
respectively.
Conclusions
Despite
high
overall
sensitivity,
lower
because
significantly
than
It
important
recognize
broad
range
avoid
an
incorrect
determination
tumor’s
organ
origin.
Language: Английский
Utility of immunocytochemistry in diagnosing abdominopelvic washings from patients undergoing radical surgery for endometrial cancer
CytoJournal,
Journal Year:
2024,
Volume and Issue:
21, P. 20 - 20
Published: June 25, 2024
Objective:
This
study
aimed
to
explore
the
efficacy
of
immunocytochemistry
in
diagnosing
abdominopelvic
washings
(APWs)
and
evaluate
superiority
cytology
combined
with
over
alone.
Material
Methods:
Data
on
APW
available
cell
blocks
from
patients
who
underwent
radical
surgery
for
endometrial
cancer
between
January
2021
December
2022
were
reviewed.
Cytology
was
re-evaluated
according
a
five-tier
system.
Immunocytochemistry
analysis
targets
such
as
Sry
box
transcription
factor
1(SOX17),
Paired
gene
2
(Pax-2)
protein,
Phosphatase
tensin
(PTEN),
β-catenin
performed
each
case
non-negative
cytology.
Mismatch
repair
(MMR)
protein
P53
analyses
using
cases
abnormal
MMR
or
expression
their
primary
lesion.
The
accuracies
alone
calculated.
Results:
Overall,
126
included
this
study,
18
whom
demonstrated
APW.
Cell
successfully
prepared
16
cases.
SOX17
positivity
observed
cases,
including
1
serous
carcinoma,
clear
14
endometrioid
carcinoma
(EC).
Loss
Pax-2
PTEN
APWs
EC.
deficiency
noted
two
EC,
mutation
another
Compared
10
metastatic
carcinomas
(10/18,
55.56%)
diagnosed
by
alone,
15
malignant
(15/18,
83.33%)
confirmed
through
combination
immunocytochemistry.
more
likely
be
than
half
myometrial
invasion
those
no
less
(
P
=
0.0067).
probability
occurrence
slightly
elevated
EC
exhibiting
microcystic,
elongated,
fragmented(MELF)
infiltrative
growth
0.039).
Conclusion:
is
useful
Müllerian
marker
distinguishing
epithelium
offers
evidence
carcinoma.
Furthermore,
positive
retained
molecular
features
similar
lesions.
use
multiple
immunocytochemical
markers
can
effectively
enhance
diagnostic
efficiency
APWs.
Language: Английский
A comprehensive analysis of SOX17 expression by immunohistochemistry in human epithelial tumors, with an emphasis on gynecologic tumors
American Journal of Clinical Pathology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 6, 2024
Abstract
Objectives
The
objective
of
this
study
was
to
evaluate
SOX17,
a
transcription
factor
from
the
Sry
high-mobility
group–related
box
superfamily,
as
diagnostic
marker
determine
site
origin
using
both
whole-tissue
sections
and
tissue
microarrays
(TMAs).
Methods
SOX17
immunohistochemistry
performed
on
gynecologic
nongynecologic
tissues
(N
=
1004)
internally
constructed
commercially
available
TMAs.
nuclear
reactivity
scored
positive
or
negative
semiquantitative
H
score
method
Results
Using
TMAs,
in
94%
(n
155)
endometrial
tumors
96%
242)
ovarian
tumors.
All
breast
cases
241)
vulvar/cervical
squamous
cell
carcinomas
150)
were
negative.
Among
1004
20
sites,
only
organs
with
ovary,
uterus,
testis.
Conclusions
is
sensitive
specific
for
tested
may
be
valuable
adjunct
PAX8
other
commonly
used
markers
confirm
origin.
expression
lower
mucinous
tumors,
endocervical
adenocarcinoma,
high-grade
neuroendocrine
undifferentiated/dedifferentiated
carcinoma.
Language: Английский
SOX17 Expression in Mesotheliomas and Benign Mesothelial Proliferations: Implications for Differential Diagnosis With Gynecologic Carcinomas
Natthawadee Laokulrath,
No information about this author
Yin P. Hung,
No information about this author
Jaclyn C. Watkins
No information about this author
et al.
International Journal of Gynecological Pathology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 31, 2024
SOX17
has
recently
emerged
as
a
novel
immunohistochemical
marker
for
cancers
of
endometrial
and
ovarian
origin
with
improved
specificity
compared
the
widely
used
Mullerian
PAX8.
However,
evaluation
in
benign
malignant
peritoneal
mesothelial
proliferations
remains
limited,
these
may
mimic
gynecologic
carcinomas,
particularly
on
small
biopsies.
We
evaluated
PAX8
expression
20
lesions
(5
adenomatoid
tumors,
5
well-differentiated
papillary
10
inclusion
cysts)
16
epithelioid
mesotheliomas.
The
17
female
3
male
patients
ranged
from
to
80
yr
(median:
56.5
yr),
while
9
females
7
males
mesothelioma
47
85
57.5
yr).
was
positive
(25%)
(2
2
(13%)
mesotheliomas,
stained
8
(40%)
(1
tumor,
1
6
cysts),
Results
stains
showed
incomplete
concordance,
agreement
15
(75%)
14
(88%)
Our
findings
suggest
that
positivity
alone
is
insufficient
confirm
diagnosis
carcinoma
over
proliferation
pathologists
should
exercise
caution
when
entities
are
diagnostic
considerations.
Language: Английский